These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28782185)

  • 1. Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.
    Zakalashvili M; Zarkua J; Weizenegger M; Bartel J; Raabe M; Zangurashvili L; Kankia N; Jashiashvili N; Lomidze M; Telia T; Kerashvili V; Zhamutashvili M; Abramishvili N; Hedskog C; Chodavarapu K; Brainard DM; McHutchison JG; Mo H; Svarovskaia E; Gish RG; Rtskhiladze I; Metreveli D
    Liver Int; 2018 Mar; 38(3):451-457. PubMed ID: 28782185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia.
    Zakalashvili M; Weizenegger M; Bartel J; Markowski M; Zarqua J; Kavsadze S; Kvatadze K; Basheleishvili G; Phirtskhalaishvili T; Dzagania T; Zangurashvili L; Kankia N; Jashiashvili N; Lomidze M; Telia T; Kerashvili V; Zhamutashvili M; Abramishvili N; Rtskhiladze I; Metreveli D
    Clin Lab; 2016 Jul; 62(7):1347-1351. PubMed ID: 28164650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
    Susser S; Dietz J; Schlevogt B; Zuckerman E; Barak M; Piazzolla V; Howe A; Hinrichsen H; Passmann S; Daniel R; Cornberg M; Mangia A; Zeuzem S; Sarrazin C
    J Hepatol; 2017 Oct; 67(4):680-686. PubMed ID: 28619439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating HCV recombinant form RF1_2k/1b in blood serum of patients by real-time RT-PCR.
    Akimov IA; Timofeev DI; Mavzyutov AR; Ivanov MK
    Klin Lab Diagn; 2021 Mar; 66(2):122-128. PubMed ID: 33734647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.
    Kurbanov F; Tanaka Y; Chub E; Maruyama I; Azlarova A; Kamitsukasa H; Ohno T; Bonetto S; Moreau I; Fanning LJ; Legrand-Abravanel F; Izopet J; Naoumov N; Shimada T; Netesov S; Mizokami M
    J Infect Dis; 2008 Nov; 198(10):1448-56. PubMed ID: 18928375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report.
    Morel V; Descamps V; François C; Fournier C; Brochot E; Capron D; Duverlie G; Castelain S
    J Clin Virol; 2010 Apr; 47(4):382-6. PubMed ID: 20153975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.
    Kalinina O; Norder H; Mukomolov S; Magnius LO
    J Virol; 2002 Apr; 76(8):4034-43. PubMed ID: 11907242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland.
    Moreau I; Hegarty S; Levis J; Sheehy P; Crosbie O; Kenny-Walsh E; Fanning LJ
    Virol J; 2006 Nov; 3():95. PubMed ID: 17107614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential risk of misclassification HCV 2k/1b strains as HCV 2a/2c using VERSANT HCV Genotype 2.0 assay.
    De Keukeleire S; Descheemaeker P; Reynders M
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):201-2. PubMed ID: 25907374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.
    Avó AP; Agua-Doce I; Andrade A; Pádua E
    J Med Virol; 2013 May; 85(5):815-22. PubMed ID: 23508907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.
    Schuermans W; Orlent H; Desombere I; Descheemaeker P; Van Vlierberghe H; Geerts A; Verhelst X; Reynders M; Padalko E
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.
    Morel V; Ghoubra F; Izquierdo L; Martin E; Oliveira C; François C; Brochot E; Helle F; Duverlie G; Castelain S
    Infect Genet Evol; 2016 Jun; 40():374-380. PubMed ID: 26444584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin.
    Hedskog C; Doehle B; Chodavarapu K; Gontcharova V; Crespo Garcia J; De Knegt R; Drenth JP; McHutchison JG; Brainard D; Stamm LM; Miller MD; Svarovskaia E; Mo H
    Hepatology; 2015 Feb; 61(2):471-80. PubMed ID: 25099344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program.
    Karchava M; Chkhartishvili N; Sharvadze L; Abutidze A; Dvali N; Gatserelia L; Dzigua L; Bolokadze N; Dolmazashvili E; Kotorashvili A; Imnadze P; Gamkrelidze A; Tsertsvadze T
    Hepatol Res; 2018 Jan; 48(1):36-44. PubMed ID: 28258606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b.
    Raghwani J; Thomas XV; Koekkoek SM; Schinkel J; Molenkamp R; van de Laar TJ; Takebe Y; Tanaka Y; Mizokami M; Rambaut A; Pybus OG
    J Virol; 2012 Feb; 86(4):2212-20. PubMed ID: 22114341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.
    Karchava M; Waldenström J; Parker M; Hallack R; Sharvadze L; Gatserelia L; Chkhartishvili N; Dvali N; Dzigua L; Dolmazashvili E; Norder H; Tsertsvadze T
    Hepatol Res; 2015 Dec; 45(13):1292-8. PubMed ID: 25689487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.
    Mourez T; Decroos A; Goria O; Montialoux H; De Oliveira F; Larrat S; Plantier JC; Riachi G
    J Med Virol; 2018 May; 90(5):994-997. PubMed ID: 29350410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.
    Trémeaux P; Caporossi A; Ramière C; Santoni E; Tarbouriech N; Thélu MA; Fusillier K; Geneletti L; François O; Leroy V; Burmeister WP; André P; Morand P; Larrat S
    Clin Microbiol Infect; 2016 May; 22(5):460.e1-460.e10. PubMed ID: 26827671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b.
    Zakalashvili M; Zarkua J; Gish RG; Zhamutashvili M; Sartania V; Weizenegger M; Bartel J; Raabe M; Gvinjilia L; Metreveli S; Barnova M; Abramishvili N; Rtskhiladze I; Metreveli D
    Hepatol Res; 2021 Feb; 51(2):156-165. PubMed ID: 33207029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.
    Gaspareto KV; Ribeiro RM; de Mello Malta F; Gomes-Gouvêa MS; Muto NH; Mendes-Correa MC; Rozanski A; Carrilho FJ; Sabino EC; Pinho JR
    Arch Virol; 2016 Aug; 161(8):2161-8. PubMed ID: 27194536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.